TLRY - Tilray, Inc.
| Previous Close | 83.45 |
| Open | 84.25 |
| Bid | 77.51 x 1100 |
| Ask | 77.44 x 1300 |
| Day's Range | 75.00 - 86.43 |
| 52 Week Range | 20.10 - 300.00 |
| Volume | 5,950,177 |
| Avg. Volume | 2,993,236 |
| Market Cap | 7.192B |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.41 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 127.50 |
- Yahoo Finance Canada•5 hours ago
Cannabis company HEXO wants to become the 'Intel Inside' of pot
Since the early 1990s, Intel Corp. (INTC) has used the slogan “Intel Inside” to tell people to buy electronics powered by their semiconductors. The ads built strong brand recognition for a company whose product is hidden from view inside computers. The chip-maker’s marketing success clearly resonated with Adam Miron, the co-founder and chief brand officer at HEXO Corp. (HEXO.TO) He envisions the Gatineau, Que.-based cannabis producer infusing its products into household-name consumer goods from shampoos to snacks.
- ACCESSWIRE•4 hours ago
Finding Bottoms for Top Profits
HENDERSON, NV / ACCESSWIRE / January 21, 2019 / Here are some of the best plays trading at or near their 52 week low, that look positioned to breakout in the near term. One that you should look at right ...
- Motley Fool•yesterday
These 4 Marijuana Stocks Could Follow Tilray Lower
Understanding how lockups work is essential for cannabis investors.
- Motley Fool•yesterday
Tilray Dodges a Bullet -- Is the Hot Marijuana Stock Now a Buy?
Tilray's IPO lockup period expiration could have been a lot worse. Is now the time to scoop up shares?
- Zacks•3 days ago
Earnings from Netflix & Big Banks, & This Week in Cannabis Deals
Ryan McQueeney and Maddy Johnson discuss earnings results from Netflix and the big U.S. banks. The hosts also remember the legacy of Jack Bogle and chat about several new cannabis industry deals.
- Zacks•3 days ago
Options Traders Expect Huge Moves in Tilray (TLRY) Stock
Tilray (TLRY) needs investors to pay close attention to the stock based on moves in the options market lately.
- Motley Fool•3 days ago
Tilray's Lock-Up Expiration Serves as a Warning for All Newly Public Pot Stocks
Lock-up expirations could be a major marijuana stock headwind in the first half of the year.
- Market Realist•3 days ago
HEXO Gets Approval to Be Listed on the NYSE American
HEXO Gets Approval to Be Listed on the NYSE AmericanHEXO On January 17, HEXO (HEXO) announced that it received approval to be listed on the NYSE (New York Stock Exchange) American. The stock will start trading under the ticker “HEXO” on January
- Market Realist•3 days ago
Price Target Update for Canopy Growth in January
Analysts' January Rating Updates for TLRY, CGC, and ACB(Continued from Prior Part)Canopy GrowthCanopy Growth (WEED) (CGC) has continued to deepen its roots in the United States with a recent announcement that could be a game changer for the company.
- Market Realist•4 days ago
What Analysts Recommend for Aurora Cannabis
Analysts' January Rating Updates for TLRY, CGC, and ACB(Continued from Prior Part)Aurora Cannabis Aurora Cannabis (ACB) stock tanked nearly 8.2% after the market closed on January 16 due to the company’s announcement that it would raise ~$250
- ACCESSWIRE•4 days ago
Cannabis Companies Expect Big Growth as Public Opinions Turn Favorable
Given that diseases are becoming more difficult to treat, it would seem that we are in desperate need of major advancements in healthcare technology, and many of these steps forward have been made possible through the advent of legalized medical marijuana. Towards the tail-end of last year, Canadian Prime Minister Justin Trudeau and members of the Canadian government agreed to legalize recreational/medicinal cannabis usage, resulting in a rush of energy for Canada's cannabis industry. With the global medical marijuana market predicted to reach $55.0 billion by 2024, according to a new research study published by Global Market Insights, Inc, it stands to reason that companies with the ability to combine the complex medical applications of cannabis with integrative healthcare frameworks could create potential opportunities from entering the nascent marijuana industry.
- Market Realist•4 days ago
Analysts’ Ratings and Price Targets for Tilray in January
Analysts' January Rating Updates for TLRY, CGC, and ACB(Continued from Prior Part)TilrayTilray (TLRY), one of the top cannabis players in Canada, has been a favorite of day traders. The company has experienced wild swings, giving a hard time to
- Market Realist•4 days ago
ACB, TLRY, and APHA Are in the Red, but CGC Continues to Gain
ACB, TLRY, and APHA Are in the Red, but CGC Continues to GainCannabis stocks are falling Aurora Cannabis (ACB) was trading in the red as of 11:00 AM EST today after the company announced that it would be raising $250 million worth of capital through
- The Motley Fool•4 days ago
Should You Buy Tilray Inc. (TSX:TLRY) or Canopy Growth Corp (TSX:WEED) Stock?
Tilray Inc. (NASDAQ:TLRY) and Canopy Growth Corp (TSX:WEED)(NYSE:CGC) are leading the cannabis industry. Is one a better bet right now?
